View in EDS HTML Full Text PDF Full Text

Determination of CSF GFAP, CCN5, and vWF Levels Enhances the Diagnostic Accuracy of Clinically Defined MS From Non-MS Patients With CSF Oligoclonal Bands.

Saved in:
Bibliographic Details
Title: Determination of CSF GFAP, CCN5, and vWF Levels Enhances the Diagnostic Accuracy of Clinically Defined MS From Non-MS Patients With CSF Oligoclonal Bands.
Authors: Probert F; Department of Chemistry, University of Oxford, Oxford, United Kingdom., Yeo T; Department of Pharmacology, University of Oxford, Oxford, United Kingdom.; Department of Neurology, National Neuroscience Institute, Singapore, Singapore.; Duke-National University of Singapore (NUS) Medical School, Singapore, Singapore., Zhou Y; Department of Pharmacology, University of Oxford, Oxford, United Kingdom.; Translational Stem Cell Biology Branch, National Institutes of Health, Bethesda, MD, United States.; Wellcome Medical Research Council (MRC) Trust Stem Cell Institute, University of Cambridge, Cambridge, United Kingdom., Sealey M; Department of Pharmacology, University of Oxford, Oxford, United Kingdom., Arora S; Department of Mathematics, University of Oxford, Oxford, United Kingdom., Palace J; Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, University of Oxford, Oxford, United Kingdom., Claridge TDW; Department of Chemistry, University of Oxford, Oxford, United Kingdom., Hillenbrand R; Biomarker Development, Novartis Pharma AG, Basel, Switzerland., Oechtering J; Neurologic Clinic and Policlinic, Multiple Sclerosis (MS) Center and Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), Departments of Clinical Research and Biomedicine, University Hospital Basel, University of Basel, Basel, Switzerland., Kuhle J; Neurologic Clinic and Policlinic, Multiple Sclerosis (MS) Center and Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), Departments of Clinical Research and Biomedicine, University Hospital Basel, University of Basel, Basel, Switzerland., Leppert D; Neurologic Clinic and Policlinic, Multiple Sclerosis (MS) Center and Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), Departments of Clinical Research and Biomedicine, University Hospital Basel, University of Basel, Basel, Switzerland., Anthony DC; Department of Pharmacology, University of Oxford, Oxford, United Kingdom.
Source: Frontiers in immunology [Front Immunol] 2022 Feb 04; Vol. 12, pp. 811351. Date of Electronic Publication: 2022 Feb 04 (Print Publication: 2021).
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 35185866
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Determination of CSF GFAP, CCN5, and vWF Levels Enhances the Diagnostic Accuracy of Clinically Defined MS From Non-MS Patients With CSF Oligoclonal Bands.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Probert+F%22">Probert F</searchLink>; Department of Chemistry, University of Oxford, Oxford, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Yeo+T%22">Yeo T</searchLink>; Department of Pharmacology, University of Oxford, Oxford, United Kingdom.; Department of Neurology, National Neuroscience Institute, Singapore, Singapore.; Duke-National University of Singapore (NUS) Medical School, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Zhou+Y%22">Zhou Y</searchLink>; Department of Pharmacology, University of Oxford, Oxford, United Kingdom.; Translational Stem Cell Biology Branch, National Institutes of Health, Bethesda, MD, United States.; Wellcome Medical Research Council (MRC) Trust Stem Cell Institute, University of Cambridge, Cambridge, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Sealey+M%22">Sealey M</searchLink>; Department of Pharmacology, University of Oxford, Oxford, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Arora+S%22">Arora S</searchLink>; Department of Mathematics, University of Oxford, Oxford, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Palace+J%22">Palace J</searchLink>; Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, University of Oxford, Oxford, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Claridge+TDW%22">Claridge TDW</searchLink>; Department of Chemistry, University of Oxford, Oxford, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Hillenbrand+R%22">Hillenbrand R</searchLink>; Biomarker Development, Novartis Pharma AG, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Oechtering+J%22">Oechtering J</searchLink>; Neurologic Clinic and Policlinic, Multiple Sclerosis (MS) Center and Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), Departments of Clinical Research and Biomedicine, University Hospital Basel, University of Basel, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Kuhle+J%22">Kuhle J</searchLink>; Neurologic Clinic and Policlinic, Multiple Sclerosis (MS) Center and Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), Departments of Clinical Research and Biomedicine, University Hospital Basel, University of Basel, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Leppert+D%22">Leppert D</searchLink>; Neurologic Clinic and Policlinic, Multiple Sclerosis (MS) Center and Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), Departments of Clinical Research and Biomedicine, University Hospital Basel, University of Basel, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Anthony+DC%22">Anthony DC</searchLink>; Department of Pharmacology, University of Oxford, Oxford, United Kingdom.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101560960%22">Frontiers in immunology</searchLink> [Front Immunol] 2022 Feb 04; Vol. 12, pp. 811351. <i>Date of Electronic Publication: </i>2022 Feb 04 (<i>Print Publication: </i>2021).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101560960 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1664-3224 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216643224%22">16643224 </searchLink><i>NLM ISO Abbreviation: </i>Front Immunol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35185866
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fimmu.2021.811351
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 811351
    Titles:
      – TitleFull: Determination of CSF GFAP, CCN5, and vWF Levels Enhances the Diagnostic Accuracy of Clinically Defined MS From Non-MS Patients With CSF Oligoclonal Bands.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Probert F
      – PersonEntity:
          Name:
            NameFull: Yeo T
      – PersonEntity:
          Name:
            NameFull: Zhou Y
      – PersonEntity:
          Name:
            NameFull: Sealey M
      – PersonEntity:
          Name:
            NameFull: Arora S
      – PersonEntity:
          Name:
            NameFull: Palace J
      – PersonEntity:
          Name:
            NameFull: Claridge TDW
      – PersonEntity:
          Name:
            NameFull: Hillenbrand R
      – PersonEntity:
          Name:
            NameFull: Oechtering J
      – PersonEntity:
          Name:
            NameFull: Kuhle J
      – PersonEntity:
          Name:
            NameFull: Leppert D
      – PersonEntity:
          Name:
            NameFull: Anthony DC
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 04
              M: 02
              Text: 2022 Feb 04
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 1664-3224
          Numbering:
            – Type: volume
              Value: 12
          Titles:
            – TitleFull: Frontiers in immunology
              Type: main
ResultId 1